MYTOLAC

Product Overview

About MYTOLAC

MYTOLAC is a prescription medication containing the active ingredient Lanreotide (Lanreotide Acetate), a synthetic analogue of somatostatin. It is used in the treatment of acromegaly, a rare hormonal disorder caused by excess growth hormone production.

Key Benefits & Uses

• Treatment of acromegaly, a condition characterized by excessive growth hormone production, leading to abnormal growth and development.
• Reduction of symptoms associated with acromegaly, such as joint pain, swelling, and sleep apnea.
• Management of symptoms related to neuroendocrine tumors, including carcinoid syndrome and pancreatic neuroendocrine tumors.

Active Ingredient & Action

Lanreotide (Lanreotide Acetate) in MYTOLAC works by mimicking the action of somatostatin, a hormone that regulates growth hormone production. By binding to somatostatin receptors, Lanreotide reduces the production and release of growth hormone, thereby alleviating symptoms associated with acromegaly.

Important Notes

MYTOLAC is available in injectable form and should only be administered under the guidance of a qualified healthcare professional. Patients with a history of pancreatitis, kidney disease, or thyroid disorders should consult their doctor before taking MYTOLAC. Common side effects may include injection site reactions, diarrhea, and abdominal pain. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of adverse effects.